You just read:

Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

News provided by

Novartis Pharmaceuticals Corporation

Jun 03, 2019, 01:19 ET